Autopsy report · NCT05998863

EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

“No enrollment due to COVID”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

University of Texas Southwestern Medical Center

Sponsor type

University, hospital or other

Conditions

Osteoporosis; Hypomagnesemia

Interventions

EffCaMgCit; Placebo

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Study of the Loss of AV Synchrony at Maximum Exercise
  “No Enrollments after COVID” (96% match in meaning)
• Regional Anesthesia to Relief Zoster Pain
  “No enrollement and covid” (84% match in meaning)
• Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults
  “not possible to enroll during COVID pandemic” (80% match in meaning)
• Effects of rTMS on Human Brain Activity
  “Never started enrollment due to COVID-19 closures” (80% match in meaning)
• Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy
  “Difficulty with enrollment secondary to COVID” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.